An open-label, multicenter, randomized controlled trial in the Netherlands that evaluates whether completely omitting aspirin after PCI in non-ST-segment elevation acute coronary syndrome patients is superior to DAPT in terms of major or minor bleeding and non-inferior to DAPT in terms of ischemic events.
Company Details
- Founded
- -
- Address
- Meibergdreef 9, Amsterdam,noord-Holland 1105 Az,netherlands
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- HQ
- Amsterdam, Noord-Holland
Legacy Questions
Legacy's LinkedIn profile is https://nl.linkedin.com/company/legacy-trial
Legacy's industry is
Research Services
Legacy's top competitors are
Wcn,
Ok-Flex,
Clear-Cad,
Boerhaave Medisch Centrum,
Fysiologic,
Amsterdam Umc Onderwijs En Opleiden.
Legacy's categories are Research Services
Legacy's founding year is 2022
